Speaking during a media café organized by the Health Journalists Network in Uganda (HEJNU), Dr. Wayengera noted that while the antiviral drug tecovirimat is globally approved for treating Mpox, it is ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Compound Annual Growth ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...

“This trial brings us closer to realizing ProLectin-M's potential as a first-line antiviral," said Dr. Leslie Ajayi, Bioxytran's Chief Medical Officer. "The consistency of our results, including 100% ...

Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, ...

Sunshine Biopharma Inc. company and executive profile by Barron's. View the latest SBFM company infomation and executive bios.

Pharmac is seeking public feedback on a proposal to simplify the criteria for people to receive Covid-19 antiviral medicines.

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

Study Shows Drop in Use of Antiviral Medications in Young Children With Influenza Dec. 17, 2024 — Despite national medical guidelines supporting the use of antiviral medications in young ...

Could Island Pharmaceutical’s ISLA-101 small molecule treatment be an answer to dengue fever? The US DoD is paying close attention.

Researchers have developed a new treatment formula—known as GS-1—that could reduce the symptoms and contagiousness of the ...